AUTHOREA
Log in Sign Up Browse Preprints

loading page

Mycophenolate Mofetil-Induced Peripheral Neuropathy In The Treatment of Membranous Glomerulonephropathy: A Case Report
  • Minoo Moghimi,
  • Zahra Nekoukar,
  • ّFarhad Gholami
Minoo Moghimi
Mazandaran University of Medical Sciences

Corresponding Author:[email protected]

Author Profile
Zahra Nekoukar
Mazandaran University of Medical Sciences
Author Profile
ّFarhad Gholami
Mazandaran University of Medical Sciences
Author Profile

Abstract

Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we describe a 66-year-old male MGN case treated with MMF and revealed acquired sensory-motor axonal polyneuropathy, which is rare and has not been reported before.

Peer review status:Published

23 Jan 2021Submitted to Clinical Case Reports
Show details
Hide details
07 Apr 2021Submission Checks Completed
07 Apr 2021Assigned to Editor
28 Apr 2021Reviewer(s) Assigned
14 Jul 2021Review(s) Completed, Editorial Evaluation Pending
30 Aug 2021Editorial Decision: Revise Minor
25 Sep 20211st Revision Received
27 Sep 2021Submission Checks Completed
27 Sep 2021Assigned to Editor
27 Sep 2021Review(s) Completed, Editorial Evaluation Pending
20 Oct 2021Editorial Decision: Accept
Dec 2021Published in Clinical Case Reports volume 9 issue 12. 10.1002/ccr3.5161